Serum von Willebrand Factor and Thymic Stromal Lymphopoietin Levels Are Associated With Asthma Predictive Index in

E Mancino1, R Nenna1, L Petrarca1

  • 1Department of Maternal Child Health and Urological Sciences, Sapienza University of Rome, Rome, Italy.

Insights

Biomarkers thymic stromal lymphopoietin (TSLP) and von Willebrand factor (vWF) may improve asthma prediction in children with recurrent wheezing. Elevated levels of TSLP and vWF were associated with a positive Asthma Predictive Index (API) score.

Area of Science:

  • Pediatric Pulmonology
  • Biomarker Discovery
  • Asthma Research

Background:

  • Recurrent wheezing affects many preschoolers, with a third developing asthma.
  • Early risk stratification for asthma is crucial for timely intervention.
  • The Asthma Predictive Index (API) aids in risk assessment, but its accuracy can be enhanced.

Purpose of the Study:

  • To investigate the potential of biological markers, specifically thymic stromal lymphopoietin (TSLP) and von Willebrand factor (vWF), in improving asthma risk prediction.
  • To assess the association between TSLP and vWF levels and the Asthma Predictive Index (API) in children with recurrent wheezing.

Main Methods:

  • A prospective cohort study enrolled 92 children aged 1-5 years with recurrent wheezing.
  • The Asthma Predictive Index (API) was used to classify children into API-positive and API-negative groups.
  • Blood samples were analyzed for complete blood count, total Immunoglobulin E, TSLP, and vWF levels.

Main Results:

  • TSLP and vWF levels were significantly higher in API-positive children compared to API-negative children (p=0.045 for TSLP, p=0.012 for vWF).
  • Multivariable analysis confirmed that elevated TSLP and vWF were independently associated with API positivity.
  • Median TSLP was 0.473 fg/mL and median vWF was 107.4% in the study cohort.

Conclusions:

  • Findings suggest a potential association between vWF, TSLP, and API status in predicting asthma risk.
  • Further longitudinal studies are necessary to validate the predictive value of these biomarkers for future asthma development.
  • TSLP and vWF may serve as valuable adjuncts to the API for early asthma risk stratification.
Abstract

Related Concept Videos

Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.